MedPath

ZYMAR

ZYMAR

Approved
DIN Number

02257270

Drug Class

Human

Market Date

Sep 27, 2004

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02257270
AIG Number0142621005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01AE06 GATIFLOXACIN
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:04.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

GATIFLOXACINActive
Strength: 0.3 % / W/V
Monograph: GATIFLOXACIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.